Looks like you clickedhttps://www.globenewswire.com/news-release/2024/04/09/2860287/0/en/Nurix-Therapeutics-Reports-First-Clinical-Evidence-of-CNS-Activity-of-NX-5948-a-Brain-Penetrant-Orally-Available-BTK-Degrader-in-Development-for-B-Cell-Malignancies.html
If you do not want to visit that page, you can close this browser tab.
